김희정
#수술후퇴원클리닉#유방암클리닉#젊은유방클리닉#미용적유방암수술
|
학력
2007 .03 ~ 2009 .02울산대학교 의학 박사
2004 .03 ~ 2006 .02울산대학교 의학 석사
1994 .03 ~ 2000 .02전북대학교 의학 학사
2004 .03 ~ 2006 .02울산대학교 의학 석사
1994 .03 ~ 2000 .02전북대학교 의학 학사
경력
2016 .03 ~ 현재서울아산병원 유방외과 부교수
2010 .03 ~ 2016 .02서울아산병원 유방외과 조교수
2009 .09Visiting doctor Dana Farber Harvard Medical School, Memorial sloan kettering cancer center
2008 .03 ~ 2010 .02서울아산병원 유방외과 임상전임강사
2005 .03 ~ 2008 .02서울아산병원 유방외과 임상강사
2001 .03 ~ 2005 .02서울아산병원 레지던트
2010 .03 ~ 2016 .02서울아산병원 유방외과 조교수
2009 .09Visiting doctor Dana Farber Harvard Medical School, Memorial sloan kettering cancer center
2008 .03 ~ 2010 .02서울아산병원 유방외과 임상전임강사
2005 .03 ~ 2008 .02서울아산병원 유방외과 임상강사
2001 .03 ~ 2005 .02서울아산병원 레지던트
논문
A retrospective prognostic evaluation analysis using the 8th edition of the American Joint Committee on Cancer staging system for breast cancer.
Characteristics and prognosis of breast cancer after liver or kidney transplantation.
Comparing Accuracy of Mammography and Magnetic Resonance Imaging for Residual Calcified Lesions in Breast Cancer Patients Undergoing Neoadjuvant Systemic Therapy.
No Association of Positive Superficial and/or Deep Margins with Local Recurrence in Invasive Breast Cancer Treated with Breast-Conserving Surgery.
Novel cancer gene variants and gene fusions of triple-negative breast cancers (TNBCs) reveal their molecular diversity conserved in the patient-derived xenograft (PDX) model.
A Randomized Feasibility Study of (18)F-Fluoroestradiol PET to Predict Pathologic Response to Neoadjuvant Therapy in Estrogen Receptor-Rich Postmenopausal Breast Cancer.
Impact of pathologic diagnosis of internal mammary lymph node metastasis in clinical N2b and N3b breast cancer patients.
Interaction between body mass index and hormone-receptor status as a prognostic factor in lymph-node-positive breast cancer.
Outcome following sentinel lymph node biopsy-guided decisions in breast cancer patients with conversion from positive to negative axillary lymph nodes after neoadjuvant chemotherapy.
Survival improvement in hormone-responsive young breast cancer patients with endocrine therapy.
A randomized feasibility study of 18F-fluoroestradiol positron emission tomography to predict pathological response to neoadjuvant systemic therapy in estrogen receptor-rich postmenopausal breast cancer.
Survival Outcome of Combined GnRH Agonist and Tamoxifen Is Comparable to That of Sequential Adriamycin and Cyclophosphamide Chemotherapy Plus Tamoxifen in
Premenopausal Patients with Lymph-Node-Negative, Hormone-Responsive, HER2-Negative, T1-T2 Breas
A proposal for a new classification of T4 breast cancer as stage IIIC: a report from the Korean Breast Cancer Society
Concurrent Gonadotropin-Releasing Hormone Agonist Administration with Chemotherapy Improves Neoadjuvant Chemotherapy Responses in Young Premenopausal Breast Cancer Patients.
Genetic polymorphism of ESR1 rs2881766 increases breast cancer risk in Korean women
Metformin increases survival in hormone receptor-positive, HER2-positive breast cancer patients with diabetes
Phase 3, open-label, randomized study comparing 3-monthly with monthly goserelin in pre-menopausal women with estrogen receptor-positive advanced breast cancer.
Changes in serum hydroxyvitamin D levels of breast cancer patients during tamoxifen treatment or chemotherapy in premenopausal breast cancer patients
Daily collection of self-reporting sleep disturbance data via a smartphone app in breast cancer patients receiving chemotherapy: a feasibility study
Diagnostic performance of breast-specific gamma imaging in the assessment of residual tumor after neoadjuvant chemotherapy in breast cancer patients
Large genomic rearrangement of BRCA1 and BRCA2 genes in familial breast cancer patients in Korea.
Treatment and survival of patients with occult breast cancer with axillary lymph node metastasis: a nationwide retrospective study
Effect Modification of Hormonal Therapy by p53 Status in Invasive Breast Cancer
Impact of seasonal and geographical differences on breast cancer survival
Survival outcomes of different treatment methods for the ipsilateral breast of occult breast cancer patients with axillary lymph node metastasis: a single center experience
Hormonal Changes during Extended Letrozole Treatment after Completion of 5 Years of Tamoxifen in Premenopausal Patients with Breast Cancer who Became Postmenopausal
Survey of the application of the korean clinical practice recommendations on breast cancer treatment: the utility of the korean breast cancer society guidelines
Efficacy of Fulvestrant in Heavily Pretreated Postmenopausal Women with Advanced Breast Cancer: A Preliminary Report
Lymph node ratio and pN staging in patients with node-positive breast cancer: a report from the Korean breast cancer society
Risk Factor for Axillary Lymph Node Metastases in Microinvasive Breast Cancer
Characteristics and prognosis of breast cancer after liver or kidney transplantation.
Comparing Accuracy of Mammography and Magnetic Resonance Imaging for Residual Calcified Lesions in Breast Cancer Patients Undergoing Neoadjuvant Systemic Therapy.
No Association of Positive Superficial and/or Deep Margins with Local Recurrence in Invasive Breast Cancer Treated with Breast-Conserving Surgery.
Novel cancer gene variants and gene fusions of triple-negative breast cancers (TNBCs) reveal their molecular diversity conserved in the patient-derived xenograft (PDX) model.
A Randomized Feasibility Study of (18)F-Fluoroestradiol PET to Predict Pathologic Response to Neoadjuvant Therapy in Estrogen Receptor-Rich Postmenopausal Breast Cancer.
Impact of pathologic diagnosis of internal mammary lymph node metastasis in clinical N2b and N3b breast cancer patients.
Interaction between body mass index and hormone-receptor status as a prognostic factor in lymph-node-positive breast cancer.
Outcome following sentinel lymph node biopsy-guided decisions in breast cancer patients with conversion from positive to negative axillary lymph nodes after neoadjuvant chemotherapy.
Survival improvement in hormone-responsive young breast cancer patients with endocrine therapy.
A randomized feasibility study of 18F-fluoroestradiol positron emission tomography to predict pathological response to neoadjuvant systemic therapy in estrogen receptor-rich postmenopausal breast cancer.
Survival Outcome of Combined GnRH Agonist and Tamoxifen Is Comparable to That of Sequential Adriamycin and Cyclophosphamide Chemotherapy Plus Tamoxifen in
Premenopausal Patients with Lymph-Node-Negative, Hormone-Responsive, HER2-Negative, T1-T2 Breas
A proposal for a new classification of T4 breast cancer as stage IIIC: a report from the Korean Breast Cancer Society
Concurrent Gonadotropin-Releasing Hormone Agonist Administration with Chemotherapy Improves Neoadjuvant Chemotherapy Responses in Young Premenopausal Breast Cancer Patients.
Genetic polymorphism of ESR1 rs2881766 increases breast cancer risk in Korean women
Metformin increases survival in hormone receptor-positive, HER2-positive breast cancer patients with diabetes
Phase 3, open-label, randomized study comparing 3-monthly with monthly goserelin in pre-menopausal women with estrogen receptor-positive advanced breast cancer.
Changes in serum hydroxyvitamin D levels of breast cancer patients during tamoxifen treatment or chemotherapy in premenopausal breast cancer patients
Daily collection of self-reporting sleep disturbance data via a smartphone app in breast cancer patients receiving chemotherapy: a feasibility study
Diagnostic performance of breast-specific gamma imaging in the assessment of residual tumor after neoadjuvant chemotherapy in breast cancer patients
Large genomic rearrangement of BRCA1 and BRCA2 genes in familial breast cancer patients in Korea.
Treatment and survival of patients with occult breast cancer with axillary lymph node metastasis: a nationwide retrospective study
Effect Modification of Hormonal Therapy by p53 Status in Invasive Breast Cancer
Impact of seasonal and geographical differences on breast cancer survival
Survival outcomes of different treatment methods for the ipsilateral breast of occult breast cancer patients with axillary lymph node metastasis: a single center experience
Hormonal Changes during Extended Letrozole Treatment after Completion of 5 Years of Tamoxifen in Premenopausal Patients with Breast Cancer who Became Postmenopausal
Survey of the application of the korean clinical practice recommendations on breast cancer treatment: the utility of the korean breast cancer society guidelines
Efficacy of Fulvestrant in Heavily Pretreated Postmenopausal Women with Advanced Breast Cancer: A Preliminary Report
Lymph node ratio and pN staging in patients with node-positive breast cancer: a report from the Korean breast cancer society
Risk Factor for Axillary Lymph Node Metastases in Microinvasive Breast Cancer
저서
유방암 환자를 위한 치료 안내서 5판
보도자료
"젊은 유방암 환자, 항암치료 후 뼈 약해져"
http://health.chosun.com/site/data/html_dir/2020/04/17/2020041702956.html
35세 미만 '젊은 유방암', 다른 쪽 재발 위험 2.5배 높아
https://www.sedaily.com/NewsView/1S767Z5M3O
http://health.chosun.com/site/data/html_dir/2020/04/17/2020041702956.html
35세 미만 '젊은 유방암', 다른 쪽 재발 위험 2.5배 높아
https://www.sedaily.com/NewsView/1S767Z5M3O
포스팅
Clinicopathologic Characteristics and Prognostic factors of pure mucinous breast cancer
The patient underwent axillary lymph node dissection was treated with a mixture of Poloxamer and Alginate (Guardix-SG®) Impact on range of action: Single-institution, prospective, randomized, double-blind investigator pilot study
Analysis of serial circulating tumor cell count during neoadjuvant systemic therapy in breast cancer patients
Clinicopathologic Characteristics and Prognostic factors of pure mucinous breast cancer
THE CLINICAL SIGNIFICANCE OF ANTI-MULLERIAN HORMONE EVALUATION IN BREAST CANCER PATIENTS WHO ARE TAKING TAMOXIFEN.
Understanding the Therapeutic Effect and Molecular Mechanism of GnRH agonist for TNBC using Patient Derived Xenograft (PDX) model
Understanding the Therapeutic Effect and Molecular Mechanism of GnRH agonist for TNBC using Patient Derived Xenograft (PDX) model
Screening for Psychological Distress in Breast Cancer Patients and Psychiatric Referral acceptance among Screen Positive Patients
A Nomogram for Predicting the Oncotype DX Recurrence Score in Women with T1-3N0-1miM0 Hormone Receptor-positive, Human Epidermal Growth Factor-2 (HER2)-negative Breast Cancer
Evaluation of Surgical Guides Using a 3D Printer in Breast Cancer Patients Who Received Neoadjuvant Chemotherapy
No negative effect of short-term delays in surgery on tumor progression and survival outcomes in invasive breast cancer.
CHEMOTHERAPY FOR NODE-NEGATIVE, HORMONE RECEPTOR-POSITIVE MUCINOUS CARCINOMA OF BREAST
Breast-specific gamma imaging versus magnetic resonance imaging in ductal carcinoma in situ: A prospective head-to-head trial
Neutrophil lymphocyte ratio(NLR) change after systemic treatment can be a predictive factor of cancer specific survival(CSS) in stage lV breast cancer.
Poor survival of the young breast cancer is due to early and late recurrence in non triple negative breast cancer
Discordance of hormone receptor and human epidermal growth factor receptor2 as a prognostic factor of survival between primary breast cancer and recurrent breast cancer.
Multiple Primary Cancers in Breast Cancer Patients
Heterogeneity of Reproductive Risk Factors for Breast Cancer According to Age and Tumor Subtype
Analysis of Treatment and Survival of Occult Breast Cancer with Axillary Lymph Node Metastasis:
Comparisons of Survival Outcomes of the Different Surgical Approaches in Occult Breast Cancer with Axillary Node Metastasis
Expression of the Claudin 1,3,4 and 7 in Triple Negative Breast Cancer : Does Not Correlate with Prognosis
Radiofrequency ablation of early breast cancer followed by surgical resection
Feasibility of sentinel lymph node biopsy after preoperative systemic chemotherapy in breast cancer patients with FNA-proven axillary lymph node metastasis
Stage, Biology and Age
Examining Bone Degeneration as a Side Effect of Treatment in Premenopausal Breast Cancer Patients
Ki 67 Expression and Oncotype DXTM Recurrence Score in Korean Breast Cancer Patients
Clinicopathologic significance of the triple negative breast cancer associated with basal phenotype : a comparison with status of androgen receptor expression
Prognostic Factors of Male Breast Cancer
Higher breast density is positively associated with larger tumor size and lymph node metastasis: A cross-sectional study of 910 Korean
The patient underwent axillary lymph node dissection was treated with a mixture of Poloxamer and Alginate (Guardix-SG®) Impact on range of action: Single-institution, prospective, randomized, double-blind investigator pilot study
Analysis of serial circulating tumor cell count during neoadjuvant systemic therapy in breast cancer patients
Clinicopathologic Characteristics and Prognostic factors of pure mucinous breast cancer
THE CLINICAL SIGNIFICANCE OF ANTI-MULLERIAN HORMONE EVALUATION IN BREAST CANCER PATIENTS WHO ARE TAKING TAMOXIFEN.
Understanding the Therapeutic Effect and Molecular Mechanism of GnRH agonist for TNBC using Patient Derived Xenograft (PDX) model
Understanding the Therapeutic Effect and Molecular Mechanism of GnRH agonist for TNBC using Patient Derived Xenograft (PDX) model
Screening for Psychological Distress in Breast Cancer Patients and Psychiatric Referral acceptance among Screen Positive Patients
A Nomogram for Predicting the Oncotype DX Recurrence Score in Women with T1-3N0-1miM0 Hormone Receptor-positive, Human Epidermal Growth Factor-2 (HER2)-negative Breast Cancer
Evaluation of Surgical Guides Using a 3D Printer in Breast Cancer Patients Who Received Neoadjuvant Chemotherapy
No negative effect of short-term delays in surgery on tumor progression and survival outcomes in invasive breast cancer.
CHEMOTHERAPY FOR NODE-NEGATIVE, HORMONE RECEPTOR-POSITIVE MUCINOUS CARCINOMA OF BREAST
Breast-specific gamma imaging versus magnetic resonance imaging in ductal carcinoma in situ: A prospective head-to-head trial
Neutrophil lymphocyte ratio(NLR) change after systemic treatment can be a predictive factor of cancer specific survival(CSS) in stage lV breast cancer.
Poor survival of the young breast cancer is due to early and late recurrence in non triple negative breast cancer
Discordance of hormone receptor and human epidermal growth factor receptor2 as a prognostic factor of survival between primary breast cancer and recurrent breast cancer.
Multiple Primary Cancers in Breast Cancer Patients
Heterogeneity of Reproductive Risk Factors for Breast Cancer According to Age and Tumor Subtype
Analysis of Treatment and Survival of Occult Breast Cancer with Axillary Lymph Node Metastasis:
Comparisons of Survival Outcomes of the Different Surgical Approaches in Occult Breast Cancer with Axillary Node Metastasis
Expression of the Claudin 1,3,4 and 7 in Triple Negative Breast Cancer : Does Not Correlate with Prognosis
Radiofrequency ablation of early breast cancer followed by surgical resection
Feasibility of sentinel lymph node biopsy after preoperative systemic chemotherapy in breast cancer patients with FNA-proven axillary lymph node metastasis
Stage, Biology and Age
Examining Bone Degeneration as a Side Effect of Treatment in Premenopausal Breast Cancer Patients
Ki 67 Expression and Oncotype DXTM Recurrence Score in Korean Breast Cancer Patients
Clinicopathologic significance of the triple negative breast cancer associated with basal phenotype : a comparison with status of androgen receptor expression
Prognostic Factors of Male Breast Cancer
Higher breast density is positively associated with larger tumor size and lymph node metastasis: A cross-sectional study of 910 Korean
영상자료
젊은 유방암 환자의 예후가 더 안 좋은가요? [AMC 병법]
https://tv.naver.com/v/9893840
김희정 교수의 유방암 Q&A
https://tv.naver.com/v/11122655
김희정 교수의 유방암 이야기
https://tv.naver.com/v/11122613
https://tv.naver.com/v/9893840
김희정 교수의 유방암 Q&A
https://tv.naver.com/v/11122655
김희정 교수의 유방암 이야기
https://tv.naver.com/v/11122613
발표자료
유방암과 혈중 Vitamin D 수치와의 상관관계
HER-2/neu 과발현된 림프절 전이 없는 조기 유방암 환자의 재발위험도
유방암 환자의 보조호르몬요법에서 프로제스테론 수용체는 예측인자적 가치가 있는가?
BRCA1/2 Associated Korean Breast Cancer has more often ER/C-ERBB2 negative phenotype
Sentinel node biopsy in patients with multifocal breast cancer
Predictor of locoregional recurrence to plan breast conservation therapy for breast cancer
Sentinel Node Biopsy in Patients with Multifocal Breast Cancer
유방암의 유두보존 유방절제술과 즉각적 유방복원수술 110예의 적응증, 술식 및 결과
유방암 환자에서 피부보존 유방절제술 및 즉각적 유방복원수술 시행 후 발생하는 폐혈전색전증에 대해 저분자량 헤파린(Enoxaparin)을 이용한 예방적 치료
Bone mineral density and the risk of breast cancer
HER-2/neu 과발현된 림프절 전이 없는 조기 유방암 환자의 재발위험도
유방암 환자의 보조호르몬요법에서 프로제스테론 수용체는 예측인자적 가치가 있는가?
BRCA1/2 Associated Korean Breast Cancer has more often ER/C-ERBB2 negative phenotype
Sentinel node biopsy in patients with multifocal breast cancer
Predictor of locoregional recurrence to plan breast conservation therapy for breast cancer
Sentinel Node Biopsy in Patients with Multifocal Breast Cancer
유방암의 유두보존 유방절제술과 즉각적 유방복원수술 110예의 적응증, 술식 및 결과
유방암 환자에서 피부보존 유방절제술 및 즉각적 유방복원수술 시행 후 발생하는 폐혈전색전증에 대해 저분자량 헤파린(Enoxaparin)을 이용한 예방적 치료
Bone mineral density and the risk of breast cancer